Nalaganje...
An update to monoclonal antibody as therapeutic option against COVID-19
With the number of Coronavirus Disease 2019 (COVID-19) cases soaring worldwide and limited vaccine availability for the general population in most countries, the monoclonal antibody (mAb) remains a viable therapeutic option to treat COVID-19 disease and its complications, especially in the elderly i...
Shranjeno v:
| izdano v: | Biosaf Health |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Chinese Medical Association Publishing House. Published by Elsevier B.V.
2021
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7872849/ https://ncbi.nlm.nih.gov/pubmed/33585808 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bsheal.2021.02.001 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|